Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population

Guo X., Lin H-M., Lin Z., Montano M., Sansores R., Wang G., DiAngelo S., Pardo A., Selman M., Floros J.

Source: Eur Respir J 2001; 18: 482-490
Journal Issue: September
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Guo X., Lin H-M., Lin Z., Montano M., Sansores R., Wang G., DiAngelo S., Pardo A., Selman M., Floros J.. Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J 2001; 18: 482-490

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Polymorphic variation in surfactant protein B is associated with COPD exacerbations
Source: Eur Respir J 2008; 32: 938-944
Year: 2008



Association between the human surfactant protein-A (SP-A) gene locus and chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 583s
Year: 2006

Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals
Source: Eur Respir J 2011; 37: 791-799
Year: 2011



Dependence of stage of severity of chronic obstructive pulmonary disease on metalloproteinase 1, 12, surfactant protein C, microsomal epoxid hydrolase gene polymorphisms
Source: Eur Respir J 2006; 28: Suppl. 50, 523s
Year: 2006

Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study
Source: Eur Respir J 2010; 36: 89-95
Year: 2010



A new mutation of surfactant protein C gene causing severe respiratory insufficiency and pulmonary fibrosis
Source: Annual Congress 2012 - Paediatric bronchology
Year: 2012


Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias
Source: Eur Respir J 2007; 29: 134-137
Year: 2007



Serum surfactant protein D: Biomarker of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012

Evaluation of plasma LL-37 and nuclear factor kappa B (NF-?B) levels in stable chronic obstructive pulmonary disease
Source: International Congress 2017 – COPD biomarkers
Year: 2017


Validity of serum surfactant protein D as a lung-specific biomarker in monitoring asthma, chronic obstructive pulmonary disease and chronic bronchitis in Lebanese patients: Preliminary results
Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases
Year: 2012


Role of ABCA3 in paediatric interstitial lung disease associated with surfactant protein C gene mutations
Source: Annual Congress 2009 - Genetics of lung diseases
Year: 2009

Elastin expression in very severe human COPD
Source: Eur Respir J 2009; 33: 324-331
Year: 2009



Reduced myofibrillar protein breakdown in stable patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 459s
Year: 2004

Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene
Source: Eur Respir J 2004; 24: 30-39
Year: 2004



Candidate gene associations in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - The biology of smoking and COPD
Year: 2008

Surfactant protein D as a potential serum marker of pulmonary emphysema
Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention
Year: 2011

Increased expression of phosphodiesterase 4 (PDE4) A, B and D in alveolar macrophages from chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2011 - Macrophages and neutrophils in chronic lung disease
Year: 2011


Relationships between C-reactive protein and disability in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005


Pulmonary function response in smokers and patients with chronic obstructive lung disease (COPD) following exposure to concentrated fine (PM2.5) particles
Source: Annual Congress 2009 - Indoor and outdoor air pollution
Year: 2009


Distinct clinical phenotypes of airways disease defined by cluster analysis
Source: Eur Respir J 2009; 34: 812-818
Year: 2009